Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Challenges in Advanced Therapy Medicinal Product Development: A Survey among Companies in Europe
Renske M.T. ten Ham, Jarno Hoekman, Anke M. Hövels, et al.
Molecular Therapy — Methods & Clinical Development (2018) Vol. 11, pp. 121-130
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Regulatory Framework for Advanced Therapy Medicinal Products in Europe and United States
Carolina Iglesias-López, Antònia Agustí, Mercè Obach, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 159
Allogeneic mesenchymal stem cell and mesenchymal stem cell-differentiated chondrocyte suppress the responses of type II collagen-reactive T cells in rheumatoid arthritis.
Zhaohui Zheng, X. Y. Li, Jin Ding, et al.
Lara D. Veeken (2007) Vol. 47, Iss. 1, pp. 22-30
Open Access | Times Cited: 155
Additive manufacturing in drug delivery: Innovative drug product design and opportunities for industrial application
Héloïse Ragelle, Sima Rahimian, Elia A. Guzzi, et al.
Advanced Drug Delivery Reviews (2021) Vol. 178, pp. 113990-113990
Closed Access | Times Cited: 58
Recreating the Endocrine Niche: Advances in Bioengineering the Pancreas
Laura Mar Fonseca, Nicerine Krause, Fanny Lebreton, et al.
Artificial Organs (2025)
Closed Access | Times Cited: 1
Two Decades of Global Progress in Authorized Advanced Therapy Medicinal Products: An Emerging Revolution in Therapeutic Strategies
Roya Ramezankhani, Shukoofeh Torabi, Neda Minaei, et al.
Frontiers in Cell and Developmental Biology (2020) Vol. 8
Open Access | Times Cited: 55
HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies
Doug Coyle, Isabelle Durand‐Zaleski, Jasmine Farrington, et al.
The European Journal of Health Economics (2020) Vol. 21, Iss. 9, pp. 1421-1437
Closed Access | Times Cited: 54
Advanced Therapy Medicinal Products
Vanessa Neuhaus, Dirk Schaudien, Susann Dehmel
Springer eBooks (2024), pp. 1521-1545
Closed Access | Times Cited: 8
Emerging technologies for quality control of cell-based, advanced therapy medicinal products
Silvia Zia, Valeria Pizzuti, Francesca Paris, et al.
Journal of Pharmaceutical and Biomedical Analysis (2024) Vol. 246, pp. 116182-116182
Open Access | Times Cited: 6
What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings
Renske M.T. ten Ham, Anke M. Hövels, Jarno Hoekman, et al.
Cytotherapy (2020) Vol. 22, Iss. 7, pp. 388-397
Open Access | Times Cited: 48
Advanced Therapy Medicinal Products Challenges and Perspectives in Regenerative Medicine
Ασπασία Γούλα, Vasiliki Gkioka, Efstathios Michalopoulos, et al.
Journal of Clinical Medicine Research (2020) Vol. 12, Iss. 12, pp. 780-786
Open Access | Times Cited: 41
Current landscape of clinical development and approval of advanced therapies
Carolina Iglesias-López, Antònia Agustí, Antonio Vallano, et al.
Molecular Therapy — Methods & Clinical Development (2021) Vol. 23, pp. 606-618
Open Access | Times Cited: 38
Mitigating Deficiencies in Evidence during Regulatory Assessments of Advanced Therapies: A Comparative Study with Other Biologicals
Magdi Elsallab, Christopher A. Bravery, Armin Kurtz, et al.
Molecular Therapy — Methods & Clinical Development (2020) Vol. 18, pp. 269-279
Open Access | Times Cited: 38
State of the Art Review of Cell Therapy in the Treatment of Lung Disease, and the Potential for Aerosol Delivery
Hosanna Brave, Ronan MacLoughlin
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 17, pp. 6435-6435
Open Access | Times Cited: 36
Regenerative medicine regulatory policies: A systematic review and international comparison
Tingting Qiu, Eve Hanna, Monique Dabbous, et al.
Health Policy (2020) Vol. 124, Iss. 7, pp. 701-713
Open Access | Times Cited: 34
Health inequity in genomic personalized medicine in underrepresented populations: a look at the current evidence
Sherouk M. Tawfik, Aliaa A. Elhosseiny, Aya Galal, et al.
Functional & Integrative Genomics (2023) Vol. 23, Iss. 1
Closed Access | Times Cited: 13
Barriers to Treg therapy in Europe: From production to regulation
Conor Hennessy, Milena Deptuła, Joanna Hester, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 11
Robotics-Driven Manufacturing of Cartilaginous Microtissues for Skeletal Tissue Engineering Applications
Isaak Decoene, Gabriele Nasello, Rodrigo Madeiro da Costa, et al.
Stem Cells Translational Medicine (2024) Vol. 13, Iss. 3, pp. 278-292
Open Access | Times Cited: 4
Exploring the Potential of Medicinal Plants in Bone Marrow Regeneration and Hematopoietic Stem Cell Therapy
Okechukwu Paul-Chima Ugwu, Ugo Alum Esther
International journal of bone marrow research. (2025) Vol. 8, Iss. 1, pp. 001-005
Closed Access
Evolution of Mesenchymal Stem Cell Therapy as an Advanced Therapeutic Medicinal Product (ATMP)—An Indian Perspective
Sathish Muthu, Madhan Jeyaraman, Moinuddin Basha Kotner, et al.
Bioengineering (2022) Vol. 9, Iss. 3, pp. 111-111
Open Access | Times Cited: 18
Bioengineering breakthroughs: The impact of stem cell models on advanced therapy medicinal product development
José Mauro Granjeiro, Priscila Grion de Miranda Borchio, I. Ribeiro, et al.
World Journal of Stem Cells (2024) Vol. 16, Iss. 10, pp. 860-872
Closed Access | Times Cited: 3
The Role and Challenges of Investigator‐Initiated Trials in the Cell and Gene Therapy Products Boom in Mainland China
Yifan Yang, Lianlian Bian, Cheng Yuan, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 2
Open Access
Impact of Excipient and Cell Concentration on the Viability, Proliferation, and Adhesion of Mesenchymal Stem Cells: Future Relevance for the Development of a New Advanced Therapy Medicinal Product
Ester Moñivas, Concepción Aguayo, Beatriz Rodera, et al.
Pharmaceutics (2025) Vol. 17, Iss. 5, pp. 642-642
Open Access
Advanced Therapy Medicinal Products for the Eye: Definitions and Regulatory Framework
Marina López‐Paniagua, Ana de la Mata, Sara Galindo, et al.
Pharmaceutics (2021) Vol. 13, Iss. 3, pp. 347-347
Open Access | Times Cited: 22
The Relevance of Advanced Therapy Medicinal Products in the Field of Transplantation and the Need for Academic Research Access: Overcoming Bottlenecks and Claiming a New Time
Lorenzo Piemonti, Hanne Scholz, Dide de Jongh, et al.
Transplant International (2023) Vol. 36
Open Access | Times Cited: 9
Synthesizing regulatory guidance for demonstrating preclinical efficacy and translating promising cell therapies to early phase clinical trials: a scoping review
Matthew S. Jeffers, Cheng Xi, Raj Bapuji, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top